|
| IOL Chemicals to invest over Rs 200 crore in capacity expansion |
| BS Reporter / Mumbai Feb 22, 2009, 00:55 IST |
|
IOL Chemicals and Pharmaceuticals (IOLCP), producers of organic chemicals and bulk drugs in India, will invest Rs 216 crore in capacity expansion for its various product lines, including its most popular pharma product Ibuprofen.
The company aims to expand the capacity of its Ibuprofen plant to 6000 TPA to cater to the new geographical markets abroad including Japan, Korea, Taiwan and few states of the USA as it has received certifications for exports of Ibuprofen to various countries.
The production capacity of Ibuprofen has been the stronghold of IOLCP’s pharmaceutical operations and the company has recently upgraded its Ibuprofen plant capacity to 3,600 TPA.
R K Thukral, executive director, IOL Chemicals and Pharmaceuticals, said, “We are working at an enormous pace to increase our manufacturing capacity to keep up with the demand of Ibuprofen, which is used to reduce fever and treat pain or inflammation caused by many ailments such as headache, toothache, back pain, arthritis, menstrual cramps, or minor injuries.”
IOLCP exports various products to many countries including Argentina, Brazil, China, Denmark, Germany, Singapore, Hong Kong, Kenya, Malaysia, Peru, Egypt etc.
|
|
|
|
|
|
|
|
|
|
 Read Business news in |  |
|
|
|
|
|
|
Advertisements |
|
|
|
|
|
|
|
|
|
|
Content Guide
